Chen, Bao-Ju; Chuko, Ju; Tung, Chi-Hua; Hu, Kuang-Yu - In: International Journal of Management, Economics and … 8 (2019) 3, pp. 253-265
Exenatide is one of a new class of medications (incretin mimetics) for the treatment of type 2 diabetes mellitus and was approved in April 2005 by the U.S. Food and Drug Administration. We undertook a systematic review and meta-analysis of exenatide therapy compared to both placebo and insulin...